The regulation of angiogenesis by tissue cell-macrophage interactions / / topic editors, Michal A. Rahat, Bernhard Hemmerlein and Vijaya Iragavarapu-Charyulu.

Angiogenesis is the physiological process where new blood vessels grow from existing ones, in order to replenish tissues suffering from inadequate blood supply. Perhaps the most studied angiogenic process occurs in solid tumors whose growing mass and expanding cells create a constant demand for addi...

Full description

Saved in:
Bibliographic Details
:
TeilnehmendeR:
Place / Publishing House:[Lausanne, Switzerland] : : Frontiers Media SA,, 2014.
Year of Publication:2014
Language:English
Series:Frontiers Research Topics,
Physical Description:1 online resource (113 pages).
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 01478nam a2200325 i 4500
001 993547505804498
005 20160616151936.0
006 m o u
007 cr |||||||||||
008 160616s2014 sz |||||o|||||||||||eng d
035 |a (CKB)3710000000586884 
035 |a (WaSeSS)IndRDA00057887 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/58034 
035 |a (EXLCZ)993710000000586884 
040 |a WaSeSS  |b eng  |e rda  |c WaSeSS 
041 0 |a eng 
050 4 |a QP106.6 
100 1 |a Bernhard Hemmerlein  |4 auth 
245 0 4 |a The regulation of angiogenesis by tissue cell-macrophage interactions /  |c topic editors, Michal A. Rahat, Bernhard Hemmerlein and Vijaya Iragavarapu-Charyulu. 
260 |b Frontiers Media SA  |c 2014 
264 1 |a [Lausanne, Switzerland] :  |b Frontiers Media SA,  |c 2014. 
300 |a 1 online resource (113 pages). 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 0 |a Frontiers Research Topics,  |x 1664-8714 
504 |a Includes bibliographical references. 
588 |a Description based on: online resource; title from pdf title page (frontiers, viewed Jun. 16, 2016). 
520 |a Angiogenesis is the physiological process where new blood vessels grow from existing ones, in order to replenish tissues suffering from inadequate blood supply. Perhaps the most studied angiogenic process occurs in solid tumors whose growing mass and expanding cells create a constant demand for additional supply of oxygen and nutrients for survival. However, other physiological and clinical conditions, such as wound healing, ischemic events, autoimmune and age-related diseases also involve angiogenesis. Angiogenesis is a well-structured process that begins when oxygen and nutrients are depleted, leading to the release of chemokines and growth factors that attract immune cells, particularly macrophages and endothelial cells to the site. Macrophages that are recruited to the site, as well as tissue cells and endothelial cells, secrete pro-angiogenic mediators that affect endothelial cells and promote angiogenesis. These mediators include growth factors such as vascular endothelial cell growth factor (VEGF), matrix metalloproteinases (MMPs), as well as low levels of mediators that are usually seen as pro-inflammatory but are pro-angiogenic when secreted in low levels (e.g. nitric oxide (NO) and TNFa). Thus, macrophages play a major role in angiogenesis. Macrophages exhibit high plasticity and are capable of shifting between different activation modes and functions according to their changing microenvironment. Small differences in the composition of activating factors (e.g. TLR ligands such as LPS, anti-inflammatory cytokines, ECM molecules) in the microenvironment may differently activate macrophages to yield classically activated macrophages (or M1 macrophages) that can kill pathogen and tumor cells, alternatively activated macrophages (or M2 macrophages) that secrete antiinflammatory cytokines, resolution macrophages (rM?) that are involved in the resolution of inflammation, or regulatory macrophages (e.g. Myeloid-Derived Suppressor Cells - MDSCs) that control the function of other immune cells. In fact, macrophages may be activated in a spectrum of subsets that may differently contribute to angiogenesis, and in particular non-classically activated macrophages such as tumor-associated macrophages (TAMs) and Tie2-expressing monocytes (TEMs) can secrete high amounts of pro-angiogenic factors (e.g. VEGF, MMPs) or low levels of pro-inflammatory mediators (e.g. NO or TNFa) resulting in pro-angiogenic effects. Although the importance of macrophages as major contributors and regulators of the angiogenic process is well documented, less is known about the interactions between macrophages and other cell types (e.g. tumor cells, normal epithelial cells, endothelial cells) that regulate angiogenesis. We still have only limited understanding which proteins or complexes mediate these interactions and whether they require cell-cell contact (e.g. through integrins) or soluble factors (e.g. the EGF-CSF-1 loop), which signaling pathways are triggered in each of the two corresponding cell types, and how this leads to secretion of pro- or antiangiogenic factors in the microenvironment. The regulation of such interactions and through them of angiogenesis, whether through post-translational modifications of proteins or via the involvement of microRNA, is still unclear. The goal of this Research Topic is to highlight these interactions and their regulation in the context of both physiological and pathological conditions. 
546 |a English 
650 0 |a Neovascularization. 
653 |a hypoxia 
653 |a Semaphorins 
653 |a Radiation 
653 |a EMMPRIN 
653 |a tumor cells 
653 |a Nitric Oxide 
653 |a Chemokines 
653 |a chitinases 
776 |z 2-88919-317-9 
700 1 |a Rahat, Michal A.,  |e editor. 
700 1 |a Hemmerlein, Bernhard,  |e editor. 
700 1 |a Iragavarapu-Charyulu, Vijaya,  |e editor. 
906 |a BOOK 
ADM |b 2023-02-22 20:37:28 Europe/Vienna  |f system  |c marc21  |a 2016-02-13 18:39:49 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338514280004498&Force_direct=true  |Z 5338514280004498  |b Available  |8 5338514280004498